A Study of BL-M08D1 in Patients With Relapsed or Refractory Lymphoid Malignancies

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study of BL-M08D1 in Patients With Relapsed or Refractory Lymphoid Malignancies	Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence	Recruiting	Phase 1	2026-01-21		NCT06718634

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.	110
Sichuan Baili Pharmaceutical Co., Ltd.	135

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Harbin Medical University Cancer Hospital	Harbin	China	51

Clinical trials